Ophthalmic innovator George Marcellino dies
George Marcellino, PhD, vice president of clinical affairs and marketing at Iridex, died unexpectedly on Feb. 10, according to a statement released by the company.
Marcellino served on the Iridex board of directors for 3 years before becoming vice president in 2018.
Before joining Iridex, Marcellino co-founded OptiMedica, where he led the development of pattern scanning laser photocoagulation for retinal disease treatment and the Catalys femtosecond laser cataract system. He spent more than 35 years in the medical device industry and was widely known throughout the medical community, the statement said.
Marcellino helped establish many devices including the Novus 2000 photocoagulator, the laser indirect ophthalmoscope system, the Selecta selective laser trabeculoplasty system, the Opal photoactivator, selective retinal therapy and Iridex’s revised MicroPulse P3 delivery device, the statement said.
In addition, he co-authored 31 peer-reviewed articles in ophthalmic journals, as well as two textbook chapters, and was the co-inventor on nine patents.